Navigation Links
FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
Date:9/22/2007

. In 2007, Genzyme was chosen to receive the National Medal of Technology, the highest honor awarded by the President of the United States for technological innovation. In 2006 and 2007, Genzyme was selected by FORTUNE as one of the "100 Best Companies to Work for" in the United States.

With many established products and services helping patients in nearly 90 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences. The company's products and services are focused on rare inherited disorders, kidney disease, orthopaedics, cancer, transplant, and diagnostic testing. Genzyme's commitment to innovation continues today with a substantial development program focused on these fields, as well as immune disease, infectious disease, and other areas of unmet medical need.

Genzyme(R) and Campath(R) are registered trademarks of Genzyme Corporation. All rights reserved.

Genzyme's press releases and other company information are available at http://www.genzyme.com and by calling Genzyme's investor information line at 1-800-905-4369 within the United States or 1-703-797-1866 outside the United States.

About Bayer HealthCare Pharmaceuticals Inc.

Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals unit of Bayer HealthCare LLC, a division of Bayer AG. Its research and business activities are focused on the following areas: Diagnostic Imaging, Hematology/Cardiology, Oncology, Primary Care, Specialized Therapeutics and Women's Healthcare. The company's aim is to discover and manufacture products that will improve human health worldwide by diagnosing, preventing and treating diseases.

For more information about Campath, including full prescribing information, call 1-888-84-BAYER (1-888-842-2937) or visit http://www.campath.com.

This press release contains forward-loo
'/>"/>

SOURCE Genzyme Corp. and Bayer HealthCare Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. FDA approves Phase 0 trial which tests experimental drugs on humans
2. FDA Approves Contraceptive Ring
3. FDA approves new device to treat womens bleeding disorder
4. FDA Approves New HIV Drug, Viread
5. FDA Approves Birth Control Skin Patch
6. FDA approves surgical gel
7. FDA Approves New Arthritis Drug, Bextra
8. FDA Approves Elidel Cream for Eczema
9. FDA approves drug for rare liver disease
10. FDA approves first pocket-sized EKG machine
11. FDA Approves New Anti-Clotting Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Blood's Thicker Than Water is based on a true ... the heart of the city. Raymond E. Blake paints this ... disrespect caused two families to collide with each other and ... Boyz and the M.O.B. Boyz clash in a rain of ... a silent terror. "Guerrilla," AKA "Real," runs his Mob family ...
(Date:8/28/2014)... August 28, 2014 Millennium Treatment Group recently ... is extremely large, and Millennium Treatment Group is working to ... that they need. , According to the National Survey ... 21 million Americans could have benefited from treatment for drug ... received help. This means that there is a large treatment ...
(Date:8/28/2014)... Lake Worth, FL (PRWEB) August 28, 2014 ... of drug use affecting users in the workplace. A ... and Drug Dependence (NCADD) states that drug abuse ... , Employees who use or are addicted to drugs ... Drug users’ activities carry over into the workplace, causing ...
(Date:8/28/2014)... 28, 2014 (HealthDay News) -- Arguments between parents may ... indicates. Parents in more than 200 families were ... At the end of each day, mothers and fathers ... with their children. On days when parents reported ... their children were also strained, according to the study ...
(Date:8/28/2014)... As the federal government plans its exit strategy from ... rethink its role in providing health care to veterans, says ... Medicine . , "To simply go on doing more of ... the Veterans Health Administration,s cost and population structure pose in ... for Health Policy & Clinical Practice, and David Auerbach, from ...
Breaking Medicine News(10 mins):Health News:Raymond E. Blake Releases Blood's Thicker Than Water, Based on a True Story 2Health News:Millennium Treatment Group Works to Close Treatment Gap 2Health News:Drug Use Causes Problems in the Workplace 2Health News:Parents' Fights May Strain Bonds With Their Kids 2Health News:A VA exit strategy 2
... may extend life for those with tumors in bile duct, ... a second chemotherapy drug to the treatment regimen of people ... to new research. , This type of cancer -- which ... notoriously difficult to treat and often fatal. , "These ...
... ... fat deposits and reshapes the body. Clinically proven, the maximus system powered by TriLipo, ... inch-loss, cellulite reduction and lax skin tightening. , ... Tel Aviv, Israel (PRWEB) April 7, 2010 - ...
... Researchers from Boston University School of Medicine (BUSM) ... have discovered a new approach for identifying smokers at ... which appear in the April 7th issue of ... use a genomic approach to prevent lung cancer in ...
... Ford Hospital have found that infection with the hepatitis ... Using administrative data from more than 67,000 Henry ... period 1997-2008, 0.6% (17/3057) patients with hepatitis C infection ... the disease developed kidney cancer. After controlling ...
... American guts don,t, study finds, , WEDNESDAY, April 7 ... human intestinal tract that help everything from digesting food ... culture because of variations in diet, researchers now report. ... microbiology by researchers in France, who identified genes in ...
... Cancer cells grow so fast that they can outstrip their ... produce energy in a way that needs less oxygen but ... Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove ... that sugar supply, causing the cells to self destruct. ...
Cached Medicine News:Health News:Progress Made Against Tough-to-Treat Biliary Tract Cancers 2Health News:Progress Made Against Tough-to-Treat Biliary Tract Cancers 3Health News:Pollogen Launches the Maximus, Advanced Solution for Fat Reduction and Body Shaping based on Innovative TriLipo Technology 2Health News:Pollogen Launches the Maximus, Advanced Solution for Fat Reduction and Body Shaping based on Innovative TriLipo Technology 3Health News:Researchers discover new approach for identifying smokers at highest risk for developing lung cancer 2Health News:Henry Ford Hospital atudy: Hepatitis C infection doubles risk for kidney cancer 2Health News:You Are What Microbes You Eat 2Health News:You Are What Microbes You Eat 3Health News:New agent chokes off energy supply, kills cancer cells 2
(Date:8/28/2014)... 28, 2014 Reportlinker.com announces ... is available in its catalogue: ... Services Industry (U.S.): Analytics, Extensive Financial ... 2021, NAIC 541380 ... Testing Laboratories, Safety and Compliance Services ...
(Date:8/28/2014)... 2014 Reportlinker.com announces that a new ... North America Laparoscopes Market Outlook to ... North America Laparoscopes Market Outlook to 2020 ... Laparoscopes Market Outlook to 2020", provides key market ... report provides value, in millions of US dollars, ...
(Date:8/28/2014)... DALLAS , Aug. 28, 2014 /PRNewswire-iReach/ -- ... Poland (Photo - ... " CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Poland ... identifies key trends in the healthcare market and ... and healthcare infrastructure. Most importantly, the report provides ...
Breaking Medicine Technology:Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 2Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 3Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 4Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 5Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 6North America Laparoscopes Market Outlook to 2020 2North America Laparoscopes Market Outlook to 2020 3North America Laparoscopes Market Outlook to 2020 4North America Laparoscopes Market Outlook to 2020 5North America Laparoscopes Market Outlook to 2020 6North America Laparoscopes Market Outlook to 2020 7North America Laparoscopes Market Outlook to 2020 8North America Laparoscopes Market Outlook to 2020 9North America Laparoscopes Market Outlook to 2020 10North America Laparoscopes Market Outlook to 2020 11Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 2Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 3Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 4Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 5
... Jan. 11 Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: ... in San Francisco. The conference will be held January 11-14, 2010, at ... 2010, 2:00 PM Pacific Time. The conference will be webcast live with ... accessed at www.celltherapeutics.com . , , ...
... , DURHAM, N.C., Jan. 8 Oxygen Biotherapeutics, ... stock has been approved for listing on the NASDAQ Capital ... the NASDAQ is a very important milestone for our company," ... on the NASDAQ provides us with greater visibility for our ...
Cached Medicine Technology:Cell Therapeutics, Inc. (CTI) to Present at the 28th Annual JP Morgan Healthcare Conference 2Oxygen Biotherapeutics, Inc. Announces Approval for NASDAQ Listing 2
... CO2 system was expressly designed to obtain ... A special source and an equally special ... create particular high energy impulses with constant ... as 'top-flat shaped') allow storage of enough ...
... PhotoLight is an exceptional condensate ... functional dimensions for ensuring a ... a constantly evolving professional market. ... working in different studios who ...
... the result of DEKA s new ... three different methods capable of restoring ... This treatment is designed to dramatically ... the combined action of a localized ...
... combines its great versatility in epilation ... with the compactness and easy-transportability of ... vascular protocols developed for Smartepil II ... is indicated for hair removal of ...
Medicine Products: